Company: RPTX
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030405
Chunk: 4

Company: Repare Therapeutics Inc.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 15
Chunk 4
---

     
    333-238822
     
    10.17
     
    May 29, 2020

    10.18†
     
    First Amendment to Collaboration and License Agreement by and between the registrant, Repare Therapeutics USA Inc. and Bristol-Myers Squibb Company, dated July 22, 2020.
     
    10-Q
     
    001-39335
     
    10.1
     
    August 13, 2020

    10.19
     
    Second Amendment to Collaboration and License Agreement by and between the registrant, Repare Therapeutics USA Inc. and Bristol-Myers Squibb Company, dated September 24, 2020.
     
    10-Q
     
    333-238822
     
    10.1
     
    November 12, 2020

    10.20
     
    Second Amendment to Lease Agreement by and between the registrant, the registrant and NEOMED Institute, dated June 11, 2020.
     
    10-Q
     
    333-238822
     
    10.2
     
    November 12, 2020

    10.21†
     
    Third Amendment to Collaboration and License Agreement by and between the registrant, Repare Therapeutics USA Inc. and Bristol-Myers Squibb Company, dated November 20, 2020.
     
    10-K
     
    001-39335
     
    10.20
     
    March 4, 2021

    10.22++
     
    Addendum to Lease Agreement by and between the registrant, Repare Therapeutics Inc. and NEOMED Institute, dated June 1, 2021.
     
    10-Q
     
    001-39335
     
    10.1
     
    August 12, 2021

    10.23++
     
    Third Amendment to Lease Agreement by and between the registrant, Repare Therapeutics Inc. and NEOMED Institute, dated June 1, 2021.
     
    10-Q
     
    001-39335
     
    10.2
     
    August 12, 2021